Related Questions:
> Cardiovascular Medicine Item 68 (DEMO)
> Cardiovascular Medicine Item 87
> Cardiovascular Medicine Item 95
> Cardiovascular Medicine Item 88
> Cardiovascular Medicine Item 40
> Cardiovascular Medicine Item 49
> Cardiovascular Medicine Item 56
> Cardiovascular Medicine Item 97
> Cardiovascular Medicine Item 130
> Cardiovascular Medicine Item 132
> Cardiovascular Medicine Item 35
> Cardiovascular Medicine Item 113
> Cardiovascular Medicine Item 73
> Cardiovascular Medicine Item 120
> Cardiovascular Medicine Item 23
> Cardiovascular Medicine Item 42
> Cardiovascular Medicine Item 24
> Cardiovascular Medicine Item 37
> Cardiovascular Medicine Item 108
> Cardiovascular Medicine Item 28
> Cardiovascular Medicine Item 61
> Cardiovascular Medicine Item 81
> Cardiovascular Medicine Item 102
> Cardiovascular Medicine Item 41
> Cardiovascular Medicine Item 114
> Cardiovascular Medicine Item 1
> Cardiovascular Medicine Item 4
> Cardiovascular Medicine Item 20
> Cardiovascular Medicine Item 125
- Newly recognized cardiovascular risk factors
- Drug-eluting stents to reduce in-stent restenosis
- Expanded indications for lipid-lowering therapy
- Recognition of cardiovascular risks of COX-2 inhibitors
2. Nabel EG. Cardiovascular disease. N Engl J Med. 2003;349:60-72. [PMID: 12840094]
3. Burke AP, Tracy RP, Kolodgie F, Malcom GT, Zieske A, Kutys R, et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation. 2002;105:2019-23. [PMID: 11980679]
4. Willerson JT, Ridker PM. Inflammation as a cardiovascular risk factor. Circulation. 2004;109:II2-10. [PMID: 15173056]
5. Ridker PM, Wilson PW, Grundy SM. Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation. 2004;109:2818-25. [PMID: 15197153]
6. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107:499-511. [PMID: 12551878]
7. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-7. [PMID: 10403851]
8. Fox CS, Vasan RS, Parise H, Levy D, O’Donnell CJ, D’Agostino RB, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study. Circulation. 2003;107:1492-6. [PMID: 12654605]
9. Gibbons RJ, Balady GJ, Bricker JT, Chaitman BR, Fletcher GF, Froelicher VF, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol. 2002;40:1531-40. [PMID: 12392846]
10. Lodge MA, Braess H, Mahmoud F, Suh J, Englar N, Geyser-Stoops S, et al. Developments in nuclear cardiology: transition from single photon emission computed tomography to positron emission tomography-computed tomography.J Invasive Cardiol. 2005;17:491-6. [PMID: 16145241]
11. Keelan PC, Bielak LF, Ashai K, Jamjoum LS, Denktas AE, Rumberger JA, et al. Long-term prognostic value of coronary calcification detected by electron-beam computed tomography in patients undergoing coronary angiography. Circulation. 2001;104:412-7. [PMID: 11468202]
12. O’Rourke RA, Brundage BH, Froelicher VF, Greenland P, Grundy SM, Hachamovitch R, et al. American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. Circulation. 2000;102:126-40. [PMID: 10880426]
13. Gibbons RJ, Abrams J, Chatterjee K, Daley F, Deedwania PC, Douglas JS, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients with Chronic Stable Angina). 2002. Available at http://www.acc.org/qualityandscience/clinical/statements.htm.
14. Snow V, Barry P, Fihn SD, Gibbons RJ, Owens DK, Williams SV, et al. Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2004;141:562-7. [PMID: 15466774]
15. Hebert PR, Hennekens CH. An overview of the 4 randomized trials of aspirin therapy in the primary prevention of vascular disease. Arch Intern Med. 2000;160:3123-7. [PMID: 11074741]
16. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT, Hunninghake DB, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation. 2004;110:227-39. [PMID: 15249516]
17. Smith SC Jr, Feldman TE, Hirshfeld JW Jr, Jacobs AK, Kern MJ, King SB 3rd, et al. ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention-summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Catheter Cardiovasc Interv. 2005;67:87-112 [PMID: 16355367]
18. Ong AT, McFadden EP, Regar E, de Jaegere PP, van Domburg RT, Serruys PW. Late angiographic stent thrombosis (LAST) events with drug-eluting stents. J Am Coll Cardiol. 2005;45:2088-92. [PMID: 15963413]
19. Appoo J, Norris C, Merali S, Graham MM, Koshal A, Knudtson ML, et al. Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation. 2004;110:II13-7. [PMID: 15364831]
20. Cameron J, Trivedi S, Stafford G, Bett JH. Five-year angiographic patency of radial artery bypass grafts. Circulation. 2004;110:II23-6. [PMID: 15364833]
21. Thiele H, Oettel S, Jacobs S, Hambrecht R, Sick P, Gummert JF, et al. Comparison of bare-metal stenting with minimally invasive bypass surgery for stenosis of the left anterior descending coronary artery: a 5-year follow-up. Circulation. 2005;112:3445-50. [PMID: 16316966]
22. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110:1168-76. [PMID: 15339866]
23. Widimsky P, Straka Z, Stros P, Jirasek K, Dvorak J, Votava J, et al. One-year coronary bypass graft patency: a randomized comparison between off-pump and on-pump surgery angiographic results of the PRAGUE-4 trial. Circulation. 2004;110:3418-23. [PMID: 15557371]
24. Lauer M, Froelicher ES, Williams M, Kligfield P. Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. Circulation. 2005;112:771-6. [PMID: 15998671]
25. Eisenberg MJ, Schechter D, Lefkovits J, Goudreau E, Deligonul U, Mak KH, et al. Utility of routine functional testing after percutaneous transluminal coronary angioplasty: results from the ROSETTA registry. J Invasive Cardiol. 2004;16:318-22. [PMID: 15156002]
26. Elhendy A, Schinkel AF, van Domburg RT, Bax JJ, Valkema R, Poldermans D. Risk stratification of patients after myocardial revascularization by stress Tc-99m tetrofosmin myocardial perfusion tomography. J Nucl Cardiol. 2003;10:615-22. [PMID: 14668773]
27. Shea ML, Conti CR, Arora RR. An update on enhanced external counterpulsation. Clin Cardiol. 2005;28:115-8. [PMID: 15813616]
28. Arora RR, Chou TM, Jain D, Fleishman B, Crawford L, McKiernan T, et al. The multicenter study of enhanced external counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol. 1999;33:1833-40. [PMID: 10362181]
29. Soran O, Kennard ED, Kfoury AG, Kelsey SF. Two-Year Clinical Outcomes After Enhanced External Counterpulsation (EECP) Therapy in Patients With Refractory Angina Pectoris and Left Ventricular Dysfunction (Report from the International EECP Patient Registry). Am J Cardiol. 2006;97:17-20. [PMID: 16377276]
30. Saririan M, Eisenberg MJ. Myocardial laser revascularization for the treatment of end-stage coronary artery disease. J Am Coll Cardiol. 2003;41:173-83. [PMID: 12535804]
31. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making. JAMA. 2000;284:835-42. [PMID: 10938172]
32. Sabatine MS, Antman EM. The thrombolysis in myocardial infarction risk score in unstable angina/non-ST-segment elevation myocardial infarction. J Am Coll Cardiol. 2003;41:89S-95S. [PMID: 12644346]
33. Braunwald E, Antman EM, Beasley JW, Califf RM, Cheitlin MD, Hochman JS, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction—summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol. 2002;40:1366-74. [PMID: 12383588]
34. Cohen M. The role of low-molecular-weight heparin in the management of acute coronary syndromes. J Am Coll Cardiol. 2003;41:55S-61S. [PMID: 12644342]
35. Ferguson JJ, Califf RM, Antman EM, Cohen M, Grines CL, Goodman S, et al; SYNERGY Trial Investigators. Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trial. JAMA. 2004;292:45-54. [PMID: 15238590]
36. Kinlay S, Schwartz GG, Olsson AG, Rifai N, Sasiela WJ, Szarek M, et al. Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) Study. Circulation. 2004;110:386-91. [PMID: 15262833]
37. Okazaki S, Yokoyama T, Miyauchi K, Shimada K, Kurata T, Sato H, et al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study. Circulation. 2004;110:1061-8. [PMID: 15326073]
38. Antman EM, Anbe DT, Armstrong PW, et al. American College of Cardiology; American Heart Association; Canadian Cardiovascular Society. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction–executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol. 2004;44:671-719. PMID: 15358045
39. Antman EM, Louwerenburg HW, Baars HF, Wesdorp JC, Hamer B, Bassand JP, et al. Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial. Circulation. 2002;105:1642-9. [PMID: 11940541]
40. Scanlon PJ, Faxon DP, Audet AM, Carabello B, Dehmer GJ, Eagle KA, et al. ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol. 1999;33:1756-824. [PMID: 10334456]
41. Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, et al. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. Global Use of Strategies to Open Occluded Coronary Arteries in Acute Coronary Syndromes IIb Investigators. N Engl J Med. 1999;341:226-32. [PMID: 10413734]
42. Mehilli J, Kastrati A, Dirschinger J, Pache J, Seyfarth M, Blasini R, et al. Sex-based analysis of outcome in patients with acute myocardial infarction treated predominantly with percutaneous coronary intervention. JAMA. 2002;287:210-5. [PMID: 11779263]
43. Collins R, Armitage J, Parish S, Sleigh P, Peto R. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet. 2003;361:2005-16. [PMID: 12814710]
44. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol. 2000;35:1122-9. [PMID: 10758950]
45. Sobel BE, Frye R, Detre KM, . Burgeoning dilemmas in the management of diabetes and cardiovascular disease: rationale for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. Circulation. 2003;107:636-42. [PMID: 12566379]

©2007. American College of Physicians. All Rights Reserved. This material has been printed from the MKSAP®14 program by the American College of Physicians. This application is licensed only for individual use and in accordance with terms defined by the owner upon initial use. For information about the product or to order, please visit www.acponline.org/catalog/mksap/14/.


Epidemiology
Coronary Artery Disease


